* Prestige Consumer Healthcare Inc PBH.N PBH is expected
to show a fall in quarterly revenue when it reports results on
August 8 for the period ending March 31 2024
* The Tarrytown New York-based company is expected to
report a
6.8% decrease in revenue to $260.414 million from $279.31
million a year ago, according to the mean estimate from 6
analysts, based on LSEG data.The company's guidance on May 15
2024, for the period ended June 30, was for revenue of $260.000
million.
* LSEG's mean analyst estimate for Prestige Consumer
Healthcare
Inc is for earnings of 86 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Prestige
Consumer
Healthcare Inc is $80.00, above its last closing price
of $67.58.
The company's guidance on May 15 2024 for the period ended June
30 was for gross profit margin of USD55.5%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 1.14 1.14 0.98 Missed -14.1
Dec. 31 2024 1.04 1.04 1.06 Beat 1.8
Sep. 30 2023 1.07 1.07 1.07 Met 0.3
Jan. 1 0001 1.01 1.01 1.06 Beat 5
Mar. 1.04 1.04 -4.83 Missed -564.4
31 2023
Jan. 1 0001 1.01 1.01 1.04 Beat 2.6
Sep. 30 2022 1.00 1.00 1.02 Beat 1.8
Jun. 30 2022 1.04 1.04 1.09 Beat 5
This summary was machine generated August 6 at 18:35 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)